Zubic Lifescience Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
- Paid Up Capital ₹ 3.35 Cr
- Company Age 9 Year, 10 Months
- Last Filing with ROC 31 Mar 2018
- Open Charges ₹ 25.60 Cr
- Revenue Growth %
- Profit Growth 8.65%
- Ebitda 8.65%
- Net Worth -0.54%
- Total Assets 20.59%
About Zubic Lifescience
Zubic Lifescience Private Limited (ZLPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 March 2015 (Nine years and ten months 18 days old ). Its registered office is in Narmada, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 3.35 Cr.
The company currently has active open charges totaling ₹25.60 Cr.
Rameshbhai Vekaria, Hareshkumar Dodia, Paraskumar Kachhadiya, and Five other members serve as directors at the Company.
Company Details
-
Location
Narmada, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24233GJ2015PTC082622
-
Company No.
082622
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
18 Mar 2015
-
Date of AGM
29 Sep 2018
-
Date of Balance Sheet
31 Mar 2018
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Zubic Lifescience?
Board Members (8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hareshkumar Dodia
|
Additional Director | 28-Feb-2019 | Current |
|
Rameshbhai Vekaria
|
Additional Director | 28-Feb-2019 | Current |
|
Paraskumar Kachhadiya
|
Director | 18-Mar-2015 | Current |
|
Jayesh Chavadiya
|
Director | 09-Oct-2015 | Current |
|
Yogesh Gajipara
|
Director | 23-Jun-2016 | Current |
|
Nilesh Poshia
|
Director | 18-Mar-2015 | Current |
Financial Performance of Zubic Lifescience.
Zubic Lifescience Private Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 8.65% increase in profit. The company's net worth dipped by a decrease of 0.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zubic Lifescience?
In 2018, Zubic Lifescience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Raichur Laboratories Private LimitedRameshbhai Vekaria is a mutual person
-
Manas Clinical Research Private LimitedHareshkumar Dodia is a mutual person
-
Khodaldham Developers Private LimitedJayesh Chavadiya is a mutual person
-
Shyam Lifecare India Private Limited
Yogesh Gajipara is a mutual person
Charges (Loans)
₹25.60 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 25.60 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 May 2016 | Others | ₹12.80 Cr | Open |
| 13 May 2016 | Others | ₹12.80 Cr | Open |
How Many Employees Work at Zubic Lifescience?
Unlock and access historical data on people associated with Zubic Lifescience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zubic Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zubic Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.